doc_id	mention	start	end
932197	 hereditary deficiency of the fifth component of complement	155	214
932197	 systemic lupus erythematosus	278	307
932197	 lupus	287	293
932197	 lupus	527	533
932197	 membranous glomerulonephritis	1618	1648
932197	 vasculitis	1649	1660
932197	 arthritis	1665	1675
932197	 bacterial infections	1768	1789
932197	 pyogenic infection	2033	2052
941901	beta hexosaminidase A	14	35
941901	beta hexosaminidase A	112	133
941901	deficiency of hex A activity	273	301
941901	hex A activity	287	301
941901	Tay-Sachs disease (TSD)	347	370
941901	TSD	366	369
941901	TSD	738	741
941901	TSD	972	975
941901	TSD	1114	1117
941901	mutant TSD gene	731	746
941901	TSD mutant	972	982
941901	hex A deficiency	1151	1167
993342	deficiency of the second component of complement	105	153
993342	deficiency of the second component of complement	257	305
993342	connective tissue disorders	352	379
993342	C2 deficiency	453	466
993342	C2 deficiency	512	525
993342	C2 deficiency	603	616
993342	C2 deficiency	734	747
993342	C2 deficiency	1337	1350
993342	C2 deficiency	1448	1461
993342	C2 deficiency	1489	1502
993342	C2 deficiency	1666	1679
9288106	ataxia-telangiectasia	40	61
9288106	Ataxia-telangiectasia (A-T)	99	126
9288106	cancer	235	241
9288106	lymphoid neoplasias	254	273
9288106	A-T	122	125
9288106	A-T	304	307
9288106	A-T	549	552
9288106	A-T	663	666
9288106	A-T	1070	1073
9288106	tumour	389	395
9288106	tumour	1160	1166
9288106	tumour	1279	1285
9288106	tumour	1517	1523
9288106	tumour	1641	1647
9288106	sporadic T-cell prolymphocytic leukaemia (T-PLL)	419	467
9288106	T-cell leukaemia	81	97
9288106	T-cell leukaemia	524	540
9288106	leukaemia	88	97
9288106	leukaemia	450	459
9288106	leukaemia	531	540
9288106	leukaemia	713	722
9288106	leukaemia	1212	1221
9288106	tumour suppressor	1160	1177
9288106	tumour suppressor	1641	1658
9288106	B-cell non-Hodgkins lymphomas (B-NHL)	1309	1346
9288106	B-NHL	1340	1345
9288106	B-NHL	1353	1358
9288106	tumours	1517	1524
9288106	T-PLL	461	466
9288106	T-PLL	606	611
9288106	T-PLL	1030	1035
9288106	T-PLL	1603	1608
9288106	T-PLL	1741	1746
9294109	Myotonic dystrophy	0	18
9294109	Myotonic dystrophy	114	132
9294109	Myotonic dystrophy (DM)	114	137
9294109	muscular disorder	158	175
9294109	DMPK	281	285
9294109	DMPK	398	402
9294109	DMPK	631	635
9294109	DMPK	681	685
9294109	DMPK	1228	1232
9294109	DMPK	1279	1283
9294109	mutant myotubes	859	874
9311732	retinoblastoma	71	85
9311732	retinoblastoma	129	143
9311732	retinoblastoma	278	292
9311732	retinoblastoma	440	454
9311732	retinoblastoma	1839	1853
9311732	retinoblastoma	1939	1953
9311732	unilateral retinoblastoma	60	85
9311732	unilateral retinoblastoma	118	143
9311732	unilateral retinoblastoma	429	454
9311732	tumor	145	150
9311732	tumor	503	508
9311732	tumor	533	538
9311732	tumor	742	747
9311732	tumor	894	899
9311732	tumor	928	933
9311732	tumor	997	1002
9311732	tumor	1093	1098
9311732	tumor	1233	1238
9311732	tumor	1792	1797
9311732	tumors	533	539
9311732	tumors	742	748
9311732	tumors	894	900
9311732	tumors	928	934
9311732	tumors	997	1003
9311732	tumors	1093	1099
9311732	tumors	1233	1239
9311732	tumors	1792	1798
9311732	multifocal tumors	1781	1798
9311732	bilateral retinoblastoma	1829	1853
9336417	ankylosing spondylitis (AS)	199	226
9336417	AS	223	225
9336417	AS	248	250
9336417	AS	808	810
9336417	AS	1512	1514
9336417	AS	1693	1695
9336417	disease	415	422
9336417	disease	863	870
9336417	disease	1055	1062
9336417	disease	1084	1091
9336417	disease	1131	1138
9336417	disease	1235	1242
9336417	disease	1272	1279
9336417	disease	1588	1595
9336417	disease severity	415	431
9336417	disease severity	1084	1100
9336417	disease concordance	1272	1291
9342365	breast and ovarian cancer	163	188
9342365	tumor	241	246
9342365	tumor	1403	1408
9358014	hereditary hemochromatosis (HH)	95	126
9358014	HH	123	125
9358014	HH	798	800
9358014	HH	945	947
9358014	cancer	1048	1054
9360520	Autosomal dominant neurohypophyseal diabetes insipidus	0	54
9360520	Autosomal dominant neurohypophyseal diabetes insipidus	131	185
9360520	Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI)	131	193
9360520	disease	210	217
9360520	disease	515	522
9360520	diabetes insipidus	36	54
9360520	diabetes insipidus	167	185
9360520	diabetes insipidus	453	471
9360520	ADNDI	187	192
9360520	ADNDI	587	592
9371490	prostate cancer	47	62
9371490	prostate cancer	387	402
9371490	prostate cancer	667	682
9371490	prostate cancer	1149	1164
9371490	prostate carcinoma	73	91
9371490	cancer	56	62
9371490	cancer	116	122
9371490	cancer	230	236
9371490	cancer	396	402
9371490	cancer	676	682
9371490	cancer	1158	1164
9371490	tumor	526	531
9371490	tumor	719	724
9371490	tumor	1065	1070
9371490	prostate tumors	710	725
9382108	Huntington disease	41	59
9382108	Huntington disease	94	112
9382108	Huntington disease (HD)	94	117
9382108	HD	114	116
9382108	HD	232	234
9382108	HD	426	428
9385378	mucopolysaccharidosis IVA	96	121
9385378	Mucopolysaccharidosis IVA (MPS IVA)	123	158
9385378	MPS IVA	150	157
9385378	MPS IVA	498	505
9385378	MPS IVA	772	779
9391879	breast/ovarian cancer	55	76
9391879	breast/ovarian cancer	127	148
9391879	breast/ovarian cancer	835	856
9391879	breast cancer	247	260
9391879	breast-ovarian cancer	281	302
9391889	congenital myotonic dystrophy	25	54
9391889	congenital myotonic dystrophy	104	133
9391889	congenital myotonic dystrophy (DM)	104	138
9391889	muscular weakness	212	229
9391889	childhood onset DM	321	339
9391889	adult type of DM	367	383
9391889	paternal transmission of congenital DM	437	475
9391889	paternal transmission of congenital DM	721	759
9391889	paternal transmission of congenital DM	978	1016
9391889	congenital DM	462	475
9391889	congenital DM	558	571
9391889	congenital DM	746	759
9391889	congenital DM	946	959
9391889	congenital DM	1003	1016
9391889	adult onset DM	607	621
9400934	retinoblastoma	59	73
9400934	retinoblastoma	151	165
9400934	retinoblastoma	753	767
9400934	retinal tumours	210	225
9400934	pineal tumours	366	380
9420335	tumor	4	9
9420335	tumor	150	155
9420335	pancreatic cancers	254	272
9425228	melanoma	52	60
9425228	melanoma	208	216
9425228	melanoma	321	329
9425228	melanoma	958	966
9425228	melanoma	1010	1018
9425228	melanoma-predisposing gene	1010	1036
9425239	myotonic dystrophy	77	95
9425239	myotonic dystrophy	127	145
9425239	myotonic dystrophy	1053	1071
9425239	DM	147	149
9425239	DM	215	217
9425239	DM	293	295
9425239	DM	963	965
9425239	disease	644	651
9425239	symptoms	760	768
9427148	Aspartylglucosaminuria	0	22
9427148	Aspartylglucosaminuria	48	70
9427148	Aspartylglucosaminuria (AGU)	48	76
9427148	AGU	72	75
9427148	AGU	203	206
9427148	AGU	354	357
9427148	AGU	559	562
9427148	disorder	87	95
9427148	disorder	419	427
9439660	ataxia-telangiectasia (ATM)	42	69
9439660	ataxia-telangiectasia (A-T)	152	179
9439660	A-T	175	178
9439660	A-T	455	458
9439660	A-T	621	624
9439660	A-T	647	650
9439660	A-T	840	843
9439660	A-T	1092	1095
9439660	malignancy	381	391
9439660	cancer	470	476
9439660	cancer	1221	1227
9439660	cancers	1221	1228
9439660	tumor	1301	1306
9443866	Ataxia-telangiectasia	0	21
9443866	ATM gene	87	95
9443866	breast cancer	215	228
9443866	ataxia-telangiectasia (A-T)	309	336
9443866	A-T	332	335
9443866	A-T	1236	1239
9443866	ATM	87	90
9443866	ATM	151	154
9443866	ATM	487	490
9443866	ATM	723	726
9448273	von Hippel-Lindau tumor suppressor gene	4	43
9448273	von Hippel-Lindau (VHL) tumor suppressor gene	123	168
9448273	human VHL cancer syndrome	209	234
9448273	sporadic renal cell carcinomas (RCC)	258	294
9448273	RCC	290	293
9448273	RCC	343	346
9448273	RCC	738	741
9448273	RCC	851	854
9448273	tumorigenic	357	368
9448273	cancer cells	571	583
9448273	cancer cells	742	754
9448273	RCC cancer cells	738	754
9448273	tumor	22	27
9448273	tumor	147	152
9448273	tumor	357	362
9448273	tumor	1200	1205
9448273	tumor	1304	1309
9450866	Piebaldism	0	10
9450866	deafness	16	24
9450866	deafness	171	179
9450866	deafness	431	439
9450866	deafness	514	522
9450866	profound congenital sensorineural deafness	137	179
9450866	auditory anomalies	330	348
9450866	piebaldism	122	132
9450866	piebaldism	464	474
9450866	piebaldism	584	594
9450866	piebaldism	675	685
9450866	Waardenburg syndrome	711	731
9457913	generalized atrophic benign epidermolysis bullosa	142	191
9457913	generalized atrophic benign epidermolysis bullosa	207	256
9457913	generalized atrophic benign epidermolysis bullosa	451	500
9457914	generalized atrophic benign epidermolysis bullosa	62	111
9457914	generalized atrophic benign epidermolysis bullosa	173	222
9457914	generalized atrophic benign epidermolysis bullosa	524	573
9457914	junctional epidermolysis bullosa	252	284
9457914	generalized blistering	291	313
9457914	skin fragility	-1	-1
9463309	anhaptoglobinemia	46	63
9463309	anhaptoglobinemia	152	169
9463309	anhaptoglobinemia	456	473
9463309	anhaptoglobinemia	1746	1763
9463309	hypohaptoglobinemia	678	697
9463309	hypohaptoglobinemia	1871	1890
9463309	hypohaptoglobinemic	879	898
9463309	hypohaptoglobinemic	986	1005
9463314	ATM mutations	0	13
9463314	ATM mutations	194	207
9463314	ATM mutations	285	298
9463314	ataxia-telangiectasia	32	53
9463314	ataxia-telangiectasia	220	241
9463314	leukemia	126	134
9463314	leukemia	1009	1017
9463314	lymphoma	136	144
9463314	lymphoma	1019	1027
9463314	lymphoma	1074	1082
9463314	breast cancer	150	163
9463314	breast cancer	613	626
9463314	ataxia-telangiectasia (A-T)	220	247
9463314	cerebellar degeneration	455	478
9463314	cerebellar degeneration	771	794
9463314	A-T phenotype	731	744
9463314	A-T	243	246
9463314	A-T	520	523
9463314	A-T	731	734
9463314	A-T	965	968
9463314	A-T	1254	1257
9463314	preleukemic T-cell proliferation	1029	1061
9463314	Hodgkin lymphoma	1066	1082
9463314	ATM mutation	0	12
9463314	ATM mutation	194	206
9463314	ATM mutation	285	297
9463314	ATM mutation	537	549
9463314	ATM mutation	1123	1135
9463314	A-T patients	965	977
9463314	A-T patients	1254	1266
9463314	mutant ATM protein	1371	1389
9463318	myotonic dystrophy	35	53
9463318	myotonic dystrophy	318	336
9463318	disease	963	970
9465039	hereditary hemochromatosis	185	211
9465039	hereditary hemochromatosis	1984	2010
9465301	Angelman syndrome	173	190
9467011	Cowden disease	53	67
9467011	Cowden disease	674	688
9467011	Bannayan-Zonana syndrome	72	96
9467011	tumour	155	161
9467011	tumour	505	511
9467011	tumour	576	582
9467011	malignancy	354	364
9467011	breast cancer	-1	-1
9467011	brain cancer	-1	-1
9467011	prostate cancer	-1	-1
9467011	kidney cancer	457	470
9467011	primary tumours	497	512
9467011	endometrial carcinomas	521	543
9467011	malignant melanoma	545	563
9467011	thyroid tumours	568	583
9467011	hamartoma syndromes	102	121
9467011	hamartoma syndromes	653	672
9467011	Cowden disease (CD; MIM 158350)	674	705
9467011	Bannayan-Zonana (BZS) or Ruvalcaba-Riley-Smith syndrome (MIM 153480)	710	778
9467011	PTEN mutations	866	880
9467011	PTEN mutations	882	896
9467011	PTEN mutations	1521	1535
9467011	nonsense point mutations	967	991
9467011	missense mutations	1427	1445
9467011	missense mutations	2596	2614
9467011	breast disease	2126	2140
9467011	breast disease	2416	2430
9467011	malignant breast disease	2406	2430
9467011	central nervous system	2664	2686
9467011	thyroid	568	575
9467011	thyroid	2688	2695
9467011	breast	429	435
9467011	breast	2126	2132
9467011	breast	2233	2239
9467011	breast	2416	2422
9467011	breast	2697	2703
9467011	skin	2705	2709
9467011	gastrointestinal tract	2714	2736
9472666	Complement component C6 deficiency	101	135
9472666	C6D	137	140
9472666	C6D	272	275
9472666	C6D	720	723
9472666	meningococcal meningitis	200	224
9472666	meningitis	214	224
9472666	meningitis	300	310
9472666	neisserial infection	320	340
9482572	aniridia	69	77
9482572	aniridia	295	303
9482572	Peters anomaly	120	134
9482572	congenital cataracts	141	161
9482572	autosomal dominant keratitis	168	196
9482572	isolated foveal hypoplasia	207	233
9497246	breast cancer	78	91
9497246	breast cancer	189	202
9497246	breast cancer	299	312
9497246	breast cancer	826	839
9497246	breast cancer	981	994
9497246	breast cancer	1616	1629
9497246	breast cancer	1863	1876
9497246	ovarian cancers	-1	-1
9497246	breast-ovarian cancer	681	702
9497246	ovarian cancer	688	702
9497246	ovarian cancer	1736	1750
9506545	autosomal dominant cerebellar ataxia type I	54	97
9506545	autosomal dominant cerebellar ataxias type I	259	303
9506545	spinocerebellar ataxias 1	304	329
9506545	SCA1	337	341
9506545	SCA1	416	420
9506545	SCA1	1081	1085
9506545	SCA1	1228	1232
9506545	SCA2	351	355
9506545	SCA2	537	541
9506545	SCA2	1098	1102
9506545	SCA2	1234	1238
9506545	SCA3/Machado-Joseph disease (MJD)	369	402
9506545	SCA3	369	373
9506545	SCA3	816	820
9506545	SCA3	1133	1137
9506545	SCA3	1244	1248
9521325	idiopathic ventricular fibrillation	42	77
9521325	idiopathic ventricular fibrillation	328	363
9521325	Ventricular fibrillation	79	103
9521325	sudden deaths	130	143
9521325	idiopathic ventricular fibrillation (IVF)	328	369
9521325	IVF	365	368
9521325	IVF	391	394
9521325	IVF	604	607
9521325	IVF	640	643
9521325	IVF	954	957
9521325	IVF	1258	1261
9521325	sudden death	130	142
9521325	sudden death	552	564
9521325	cardiac rhythm disturbance	651	677
9521421	Mucopolysaccharidosis IVA	173	198
9521421	Mucopolysaccharidosis IVA (MPS IVA)	173	208
9521421	MPS IVA	200	207
9521421	MPS IVA	476	483
9521421	MPS IVA	593	600
9521421	MPS IVA	1889	1896
9521421	clinical phenotype	515	533
9521421	clinical phenotype	669	687
9521421	severe clinical phenotype	508	533
9521421	clinical phenotypes	669	688
9521421	severe	508	514
9521421	severe	690	696
9521421	severe	998	1004
9521421	intermediate	708	720
9521421	mild phenotype	157	171
9521421	mild phenotype	1260	1274
9521421	severe phenotype	998	1014
9529364	constitutional WT1 mutations	18	46
9529364	isolated diffuse mesangial sclerosis	65	101
9529364	Denys-Drash syndrome (DDS)	356	382
9529364	diffuse mesangial sclerosis (DMS)	387	420
9529364	pseudohermaphroditism	437	458
9529364	Wilms tumor (WT)	466	482
9529364	DDS	378	381
9529364	DDS	502	505
9529364	DDS	704	707
9529364	DDS	996	999
9529364	isolated DMS (IDMS)	675	694
9529364	urogenital abnormalities	720	744
9529364	WT	33	35
9529364	WT	227	229
9529364	WT	479	481
9529364	WT	752	754
9529364	WT	766	768
9529364	WT	883	885
9529364	WT	1013	1015
9529364	WT	1206	1208
9529364	WT1 mutations	33	46
9529364	WT1 mutations	883	896
9529364	WT1 mutations	1013	1026
9529364	IDMS	689	693
9529364	IDMS	834	838
9529364	IDMS	864	868
9529364	IDMS	953	957
9529364	IDMS	1058	1062
9529364	genetic heterogeneity of this disease	1084	1121
9529364	WT1 mutation	33	45
9529364	WT1 mutation	883	895
9529364	WT1 mutation	1013	1025
9529364	WT1 mutation	1206	1218
9529364	DMS	416	419
9529364	DMS	684	687
9529364	DMS	690	693
9529364	DMS	835	838
9529364	DMS	865	868
9529364	DMS	954	957
9529364	DMS	1059	1062
9529364	DMS	1420	1423
9529364	DMS	1449	1452
9529364	female phenotype	1520	1536
9529364	sexual ambiguity	1569	1585
9529364	male phenotype	1522	1536
9529364	male phenotype	1589	1603
9536083	BRCA1 mutation	13	27
9536083	BRCA1 mutation	1152	1166
9536083	familial breast and ovarian cancer	188	222
9536083	breast and ovarian cancer	197	222
9536083	185delAG mutation	123	140
9536083	185delAG mutation	770	787
9536083	185delAG mutation	894	911
9536083	185delAG mutation	1276	1293
9536083	breast/ovarian cancer	929	950
9536083	185delAG BRCA1 mutation	4	27
9536083	185delAG BRCA1 mutation	1143	1166
9546397	hereditary hemochromatosis	195	221
9546397	hemochromatosis	25	40
9546397	hemochromatosis	206	221
9546397	hemochromatosis	414	429
9554743	Wilson disease	111	125
9554743	Wilson disease	277	291
9554743	Wilson disease	748	762
9563950	Myotonic dystrophy	81	99
9563950	DM	101	103
9563950	DM	170	172
9563950	DM	192	194
9563950	DM	672	674
9563950	DM	858	860
9580132	familial neurohypophyseal diabetes insipidus	140	184
9580132	Familial neurohypophyseal diabetes insipidus (FNDI)	186	237
9580132	FNDI	232	236
9580132	FNDI	463	467
9580132	FNDI	1173	1177
9585583	Saethre-Chotzen syndrome	25	49
9585583	Saethre-Chotzen syndrome	131	155
9585583	Saethre-Chotzen syndrome	561	585
9585583	craniosynostosis	198	214
9585583	TWIST mutations	322	337
9585583	TWIST mutations	648	663
9585583	TWIST mutations	688	703
9585583	TWIST mutations	824	839
9585583	TWIST mutations	1061	1076
9585583	FGFR mutations	68	82
9585583	FGFR mutations	532	546
9585583	FGFR mutations	1080	1094
9585583	craniosynostotic condition	1197	1223
9585583	Saethre-Chotzen	25	40
9585583	Saethre-Chotzen	131	146
9585583	Saethre-Chotzen	561	576
9585583	Saethre-Chotzen	1232	1247
9585583	Crouzon	1249	1256
9585583	Pfeiffer syndromes	1262	1280
9585605	Angelman syndrome	30	47
9585605	Angelman syndrome	58	75
9585605	Angelman syndrome (AS)	58	80
9585605	AS	77	79
9585605	AS	402	404
9585605	AS	981	983
9585605	AS	1025	1027
9585605	AS	1067	1069
9585606	hemochromatosis	4	19
9585606	hemochromatosis	231	246
9585606	hemochromatosis	473	488
9585611	attenuated adenomatous polyposis coli	35	72
9585611	attenuated adenomatous polyposis coli	140	177
9585611	tumor	101	106
9585611	tumor	1375	1380
9585611	APC	118	121
9585611	APC	180	183
9585611	APC	238	241
9585611	APC	429	432
9585611	APC	515	518
9585611	APC	570	573
9585611	APC	653	656
9585611	APC	759	762
9585611	APC	1261	1264
9585611	APC	1439	1442
9585611	APC	1473	1476
9585611	attenuated adenomatous polyposis coli (AAPC)	140	184
9585611	familial adenomatous polyposis (FAP)	199	235
9585611	AAPC	179	183
9585611	AAPC	237	241
9585611	AAPC	428	432
9585611	AAPC	569	573
9585611	AAPC	1260	1264
9585611	AAPC	1438	1442
9585611	colorectal cancer	321	338
9585611	germ-line APC mutations	643	666
9585611	colorectal adenomas	899	918
9585611	colorectal adenomas	1305	1324
9585611	upper-gastrointestinal manifestations	984	1021
9585611	adenomas	291	299
9585611	adenomas	910	918
9585611	adenomas	1132	1140
9585611	adenomas	1316	1324
9585611	desmoid tumors	1367	1381
9585611	FAP9590178	-1	-1
9590178	Wilms tumor 1 (WT1)	146	165
9590178	male pseudohermaphroditism	538	564
9590178	Denys-Drash syndrome	568	588
9590178	sex-reversal	674	686
9590284	Prader-Willi syndrome	18	39
9590284	Prader-Willi syndrome	283	304
9590284	PWS	306	309
9590284	PWS	373	376
9590284	PWS	546	549
9590284	PWS	617	620
9590284	PWS	754	757
9590284	PWS infants	754	765
9600235	ataxia-telangiectasia	47	68
9600235	ataxia-telangiectasia	298	319
9600235	A-T	165	168
9600235	A-T	321	324
9600235	A-T	401	404
9600235	A-T	555	558
9600235	human recessive disease ataxia-telangiectasia	274	319
9600235	Japanese A-T patients	392	413
9600235	A-T families	555	567
9600235	A-T patients	401	413
9603435	subacute G(M2) gangliosidosis	124	153
9603435	Tay-Sachs disease (TSD)	285	308
9603435	G (M2) gangliosidosis	338	359
9603435	G (M2) gangliosidosis	737	758
9603435	subacute (juvenile-onset)	382	407
9603435	chronic (adult-onset)	412	433
9603435	infantile disease-causing	828	853
9603435	infantile TSD	1460	1473
9603435	Hex A enzyme deficiency	1678	1701
9618166	Pendred syndrome	35	51
9618166	Pendred syndrome	53	69
9618166	Pendred syndrome	1189	1205
9618166	early childhood deafness	122	146
9618166	goiter	151	157
9618170	X-linked dilated cardiomyopathy	77	108
9618170	X-linked dilated cardiomyopathy	110	141
9618170	X-linked dilated cardiomyopathy (XLDCM)	110	149
9618170	dystrophinopathy	177	193
9618170	skeletal myopathy	292	309
9618170	XLDCM	143	148
9618170	XLDCM	422	427
9618170	XLDCM	508	513
9618170	XLDCM	659	664
9618170	XLDCM	1151	1156
9620771	Severe early-onset obesity	0	26
9620771	adrenal insufficiency	28	49
9620771	adrenal insufficiency	1592	1613
9620771	isolated ACTH deficiency	389	413
9620771	human obesity	696	709
9620771	human obesity	815	828
9620771	obesity	19	26
9620771	obesity	702	709
9620771	obesity	821	828
9620771	obesity	1001	1008
9620771	obesity	1583	1590
9620771	ACTH deficiency	398	413
9620771	ACTH deficiency	1041	1056
9620771	early-onset obesity	7	26
9620771	early-onset obesity	1571	1590
9620771	red hair pigmentation	54	75
9620771	red hair pigmentation	1618	1639
9634518	phenylalanine hydroxylase deficiency	32	68
9634518	Phenylketonuria (PKU)	177	198
9634518	mild hyperphenylalaninemia (MHP)	203	235
9634518	PAH deficiency	413	427
9634518	PAH deficiency	1442	1456
9634518	metabolic phenotypes	389	409
9634518	metabolic phenotype	156	175
9634518	metabolic phenotype	389	408
9634518	metabolic phenotype	1400	1419
9634518	hyperphenylalaninemia	208	229
9634518	hyperphenylalaninemia	1640	1661
9668171	myotonic dystrophy (DM)	324	347
9668171	DM	267	269
9668171	DM	291	293
9668171	DM	344	346
9668171	DM	648	650
9668171	DM	879	881
9668171	DM	1165	1167
9668171	DM	1545	1547
9668171	DM	1552	1554
9668171	human genetic diseases	661	683
9671401	retinoblastoma	45	59
9671401	retinoblastoma	282	296
9671401	tumor	105	110
9671401	tumor	365	370
9671401	tumor	800	805
9671401	retinoblastoma phenotype	282	306
9671401	tumors	365	371
9671401	tumors	800	806
9671401	predisposing mutation	879	900
9674903	Prader-Willi syndrome	20	41
9674903	Prader-Willi syndrome	237	258
9674903	Prader-Willi syndrome (PWS)	237	264
9674903	PWS	260	263
9674903	PWS	320	323
9674903	PWS	534	537
9674903	PWS	864	867
9674903	PWS	961	964
9674903	PWS	1722	1725
9674903	PWS	1838	1841
9674906	Schwartz-Jampel syndrome type 2	0	31
9674906	Stuve-Wiedemann syndrome	36	60
9674906	Stuve-Wiedemann syndrome	335	359
9674906	Schwartz-Jampel syndrome (SJS)	180	210
9674906	myotonia	214	222
9674906	skeletal dysplasia	227	245
9674906	skeletal dysplasia	408	426
9674906	skeletal dysplasia	986	1004
9674906	SJS type 2	263	273
9674906	SJS type 2	621	631
9674906	SJS type 2	1251	1261
9674906	SJS type 2	1373	1383
9674906	Stuve-Wiedemann syndrome (SWS)	335	365
9674906	campomelia	383	393
9674906	contractures	428	440
9674906	contractures	838	850
9674906	early death	446	457
9674906	neonatal SJS	720	732
9674906	SWS	361	364
9674906	SWS	665	668
9674906	SWS	736	739
9674906	SWS	1272	1275
9674906	SWS	1365	1368
9674906	severe	769	775
9674906	congenital joint contractures	821	850
9674906	respiratory and feeding difficulties	852	888
9674906	tendency to hyperthermia	890	914
9674906	frequent death in infancy	920	945
9674906	campomelic-metaphyseal skeletal dysplasia	963	1004
9674906	progressive bone dysplasia	1194	1220
9689113	severe von Willebrand disease	17	46
9689113	severe von Willebrand disease	132	161
9689113	von Willebrand disease	24	46
9689113	von Willebrand disease	139	161
9689113	von Willebrand disease	1085	1107
9689113	vWf deficiency	-1	-1
9689113	defects in hemostasis	48	69
9689113	defects in hemostasis	496	517
9689113	thrombosis	74	84
9689113	thrombosis	769	779
9689113	prolonged bleeding time	532	555
9689113	spontaneous bleeding events	560	587
9689113	factor VIII level	651	668
9689113	defective thrombosis	-1	-1
9689113	severe human von Willebrand disease	1072	1107
9700175	hereditary ovarian cancer	36	61
9700175	hereditary ovarian cancer	416	441
9700175	ovarian cancer	47	61
9700175	ovarian cancer	211	225
9700175	ovarian cancer	263	277
9700175	ovarian cancer	364	378
9700175	ovarian cancer	427	441
9700175	ovarian cancer	925	939
9700175	ovarian cancer	1244	1258
9700175	ovarian cancer	1528	1542
9702690	adrenoleukodystrophy	23	43
9702690	adrenoleukodystrophy	163	183
9702690	ALD	185	188
9702690	ALD	242	245
9702690	ALD	511	514
9702690	ALD	1194	1197
9702690	ALD	1407	1410
9702690	ALD	1703	1706
9702690	adrenoleukodystrophy (ALD)	163	189
9702690	adult cerebral and cerebello-brain stem forms	393	438
9702690	childhood ALD type	501	519
9702690	childhood ALD	501	514
9702690	childhood ALD	1184	1197
9702690	adolescent form	589	604
9702690	Alzheimers disease (AD)	703	726
9702690	abnormalities in the bilateral cerebellar hemispheres and brain stem	776	844
9702690	demyelination of the cerebral white matter	1079	1121
9702690	neuronal degeneration in ALD	1678	1706
9703418	complement C9 deficiency	87	111
9703418	complement deficiency	191	212
9703418	C9 deficiency	98	111
9703418	C9 deficiency	288	301
9703418	C9 deficiency	882	895
9703418	C9-deficient	319	331
9703418	C9-deficient	517	529
9703418	meningococcal meningitis	363	387
9703501	breast and ovarian cancer	77	102
9703501	oxidative DNA damage	51	71
9703501	oxidative DNA damage	556	576
9703501	oxidative DNA damage	752	772
9705283	aniridia	425	433
9705283	aniridia	592	600
9705283	aniridia	1524	1532
9705283	Peters anomaly	435	449
9705283	autosomal dominant keratitis	451	479
9705283	familial foveal dysplasia	485	510
9705283	Aniridia	757	765
9709714	very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency	-1	-1
9709714	VLCAD deficiency	364	380
9709714	VLCAD deficiency	535	551
9709714	VLCAD deficiency	1061	1077
9709714	severe hypertrophic cardiomyopathy	12	46
9709714	severe hypertrophic cardiomyopathy	424	458
9709714	hepatomegaly	460	472
9709714	encephalopathy	474	488
9709714	hypotonia	494	503
9709714	cardiomyopathy	32	46
9709714	cardiomyopathy	444	458
9709714	cardiomyopathy	1149	1163
9714764	insulin-dependent diabetes mellitus (IDDM)	171	213
9724771	colorectal tumors	55	72
9724771	colorectal tumors	926	943
9724771	Classical familial adenomatous polyposis (FAP)	112	158
9724771	disease	199	206
9724771	colorectal adenomas	252	271
9724771	colorectal adenomas	549	568
9724771	colorectal adenomas	1041	1060
9724771	colorectal adenomas	1558	1577
9724771	carcinoma	276	285
9724771	carcinoma	1068	1077
9724771	carcinoma	1582	1591
9724771	FAP	154	157
9724771	FAP	359	362
9724771	FAP	638	641
9724771	FAP	1639	1642
9724771	attenuated adenomatous polyposis coli	366	403
9724771	multiple adenomas	674	691
9724771	multiple adenomas	955	972
9724771	metaplastic polyps of the colorectum	1392	1428
9724771	colorectal cancer	1677	1694
9729124	congenital chloride diarrhea (CLD)	31	65
9729124	Congenital chloride diarrhea (CLD)	72	106
9729124	CLD	61	64
9729124	CLD	102	105
9729124	CLD	249	252
9729124	CLD	643	646
9729124	CLD	900	903
9729124	disease	780	787
9729124	Pendred syndrome	971	987
9731533	familial adenomatous polyposis (FAP)	132	168
9731533	disorder	208	216
9731533	colorectal cancer (CRC)	316	339
9731533	tumours	401	408
9731533	CRC	335	338
9731533	CRC	741	744
9731533	colorectal	316	326
9731533	colorectal	880	890
9731533	breast and other cancers	892	916
9733027	Friedreich ataxia	24	41
9733027	Friedreich ataxia	124	141
9733027	premutation	42	53
9733027	premutation	305	316
9733027	premutation	385	396
9733027	premutation	908	919
9733027	premutation carrier	42	61
9733027	premutation carrier	385	404
9733027	premutation carrier	908	927
9733027	affected	621	629
9733027	affected	844	852
9733027	affected child	844	858
9744473	metachromatic leukodystrophy	53	81
9744473	metachromatic leukodystrophy	143	171
9744473	arylsulfatase A (ARSA) enzyme activity	97	135
9744473	metachromatic leukodystrophy (MLD)	143	177
9744473	MLD	173	176
9744473	MLD	227	230
9744473	MLD	320	323
9744473	MLD	750	753
9770531	von Hippel-Lindau (VHL)	161	184
9770531	renal cell carcinoma	56	76
9770531	renal cell carcinoma	219	239
9770531	renal cell carcinoma	750	770
9770531	human cancers	1172	1185
9770531	cancer	1178	1184
9770531	cancer	1358	1364
9771706	diabetes mellitus	68	85
9771706	diabetes mellitus	265	282
9771706	optic atrophy	90	103
9771706	optic atrophy	299	312
9771706	Wolfram syndrome	105	121
9771706	Wolfram syndrome	124	140
9771706	WFS	142	145
9771706	WFS	458	461
9771706	WFS	548	551
9771706	WFS	642	645
9771706	WFS	720	723
9771706	insulin-dependent diabetes mellitus	247	282
9771706	disease	423	430
9771706	disease	701	708
9774970	tumor	63	68
9774970	BRCA1	47	52
9774970	BRCA1	116	121
9774970	BRCA1	294	299
9774970	BRCA1	463	468
9774970	BRCA1	600	605
9774970	BRCA2	57	62
9774970	BRCA2	126	131
9774970	BRCA2	304	309
9774970	BRCA2	480	485
9774970	BRCA2	610	615
9774970	familial	158	166
9774970	breast and/or ovarian cancer	180	208
9774970	breast and/or ovarian cancer	845	873
9774970	hereditary breast and/or ovarian cancer	834	873
9790667	cerebrotendinous xanthomatosis	269	299
9790667	CTX	301	304
9792409	ataxia-telangiectasia	36	57
9792409	ataxia-telangiectasia	180	201
9792409	A-T	203	206
9792409	A-T	284	287
9792409	A-T	1019	1022
9792409	A-T	1077	1080
9792409	A-T	1526	1529
9792409	classical A-T	274	287
9792409	classical A-T	1516	1529
9792860	autosomal recessive Alport syndrome	89	124
9792860	autosomal recessive Alport syndrome	716	751
9792861	breast cancer	138	151
9792861	breast cancer	210	223
9792861	breast cancer	967	980
9792861	breast cancer	1029	1042
9792861	breast cancer	1453	1466
9792861	ovarian cancer	64	78
9792861	ovarian cancer	235	249
9792861	ovarian cancer	807	821
9792861	ovarian cancer	1478	1492
9792861	breast/ovarian cancer	228	249
9792861	breast/ovarian cancer	1471	1492
9800909	cognitive impairment	56	76
9800909	cognitive impairment	288	308
9800909	cognitive impairment	912	932
9800909	cognitive impairment	1226	1246
9800909	Duchenne muscular dystrophy	80	107
9800909	Duchenne muscular dystrophy	205	232
9800909	Duchenne muscular dystrophy (DMD)	205	238
9800909	cerebral dysfunction	1039	1059
9800909	DMD	234	237
9800909	DMD	326	329
9800909	DMD	481	484
9800909	DMD	1168	1171
9800909	DMD	1263	1266
9831355	hereditary non-polyposis colorectal cancer	59	101
9831355	hereditary non-polyposis colorectal cancer	133	175
9831355	hereditary non-polyposis colorectal cancer (HNPCC)	133	183
9831355	colorectal cancer	84	101
9831355	colorectal cancer	158	175
9831355	colorectal cancer	325	342
9831355	cancer	95	101
9831355	cancer	169	175
9831355	cancer	336	342
9831355	cancer	622	628
9843038	hereditary coproporphyria	65	90
9843038	Hereditary coproporphyria (HCP)	99	130
9843038	HCP	126	129
9843038	HCP	320	323
9848786	Human complement factor H deficiency	0	36
9848786	hemolytic uremic syndrome	53	78
9848786	hemolytic uremic syndrome	296	321
9848786	Factor H (FH)	169	182
9848786	acute renal disease	204	223
9848786	idiopathic hemolytic uremic syndrome (HUS)	285	327
9848786	homozygous deficiency	361	382
9848786	homozygous deficiency	627	648
9848786	Factor H-like protein 1 (FHL-1)	495	526
9848786	FH-related protein (FHR)	537	561
9848786	Factor H deficiency	891	910
9848786	complement deficiency	923	944
9848786	HUS	323	326
9848786	HUS	961	964
9848786	HUS	1061	1064
9848786	idiopathic HUS	1050	1064
9852676	myotonic dystrophy (DM)	144	167
9852676	DM	164	166
9852676	DM	306	308
9852676	DM	370	372
9852676	DM	524	526
9852676	DM	718	720
9852676	DM	917	919
9852676	DM	1258	1260
9852676	Friedreichs ataxia	1265	1283
9856498	C6 deficiency	23	36
9856498	C6 deficiency	289	302
9856498	human complement (C6)	109	130
9856498	Meningococcal disease	210	231
9856498	total C6 deficiency (C6Q0)	283	309
9856498	C6Q0	304	308
9856498	C6Q0	1048	1052
9856498	C6-deficient	1150	1162
9856499	Complement C7 deficiency	0	24
9856499	C7 deficiency	11	24
9856499	C7 deficiency	131	144
9861003	bipolar affective disorder	105	131
9861003	BPAD	187	191
9861003	BPAD	409	413
9861003	BPAD	544	548
9861003	BPAD	651	655
9861003	BPAD	932	936
9861003	BPAD	1484	1488
9861003	manic-depressive illness	193	217
9861003	psychiatric disorder	760	780
9861003	affective disorders	1515	1534
9863607	myotonic dystrophy	26	44
9863607	myotonic dystrophy	225	243
9863607	Myotonic dystrophy (DM)	46	69
9863607	autosomal dominant disease	76	102
9863607	congenital myotonic dystrophy (CDM)	214	249
9863607	DM	66	68
9863607	DM	246	248
9863607	DM	276	278
9863607	DM	405	407
9863607	DM	476	478
9863607	DM	513	515
9863607	DM	684	686
9863607	DM	917	919
9863607	DM	982	984
9863607	DM	998	1000
9863607	DM	1071	1073
9867744	hemochromatosis	13	28
9867744	hemochromatosis	44	59
9867744	hemochromatosis	682	697
9867744	hemochromatosis	793	808
9867744	hemochromatosis	904	919
9867744	iron overload	452	465
9867744	cirrhosis	533	542
9867744	cirrhosis	935	944
9867744	hepatic cirrhosis	927	944
9867744	chronic disease	999	1014
9869602	colorectal cancer	98	115
9869602	colorectal cancer	204	221
9869602	colorectal cancer	348	365
9869602	colorectal cancer	484	501
9869602	colorectal cancer	777	794
9869602	colorectal cancer	1381	1398
9869602	colorectal neoplasia	-1	-1
9869602	noncolonic neoplasia	1187	1207
9869602	cancers	1307	1314
9888388	hereditary coproporphyria	66	91
9888388	acute hepatic porphyria	150	173
9888388	neurological dysfunction	357	381
9888388	infectious diseases	450	469
9888388	Skin photosensitivity	471	492
9888388	CPO gene defects	1967	1983
9888390	metachromatic leukodystrophy	92	120
9888390	metachromatic leukodystrophy	239	267
9888390	MLD	269	272
9888390	MLD	572	575
9888390	MLD	1289	1292
9888390	MLD	1440	1443
9888390	MLD	1557	1560
9888390	MLD-like	1557	1565
9888390	clinical disease	1611	1627
9888390	disease	1620	1627
9888390	disease	1880	1887
9927033	Human MLH1 deficiency	0	21
9927033	hematological malignancy	37	61
9927033	hematological malignancy	415	439
9927033	neurofibromatosis type 1	66	90
9927033	neurofibromatosis type 1	505	529
9927033	neurofibromatosis type 1	843	867
9927033	hereditary nonpolyposis colorectal cancer	166	207
9927033	hereditary nonpolyposis colorectal cancer	352	393
9927033	neurofibromatosis type 1 (NF1)	505	535
9927033	MLH1 mutation	631	644
9927033	MLH1 mutation	698	711
9927033	mismatch repair deficiency	727	753
9927033	leukemia	802	810
9927033	lymphoma	818	826
9931324	human congenital eye malformations	97	131
9931324	aniridia (congenital absence of the iris)	175	216
9931324	aniridia	175	183
9931324	aniridia	293	301
9931324	aniridia	742	750
9931324	aniridia	976	984
9931324	aniridia	1208	1216
9931324	ectopia pupillae (displaced pupils)	1083	1118
9931324	congenital nystagmus	1123	1143
9931324	PAX6 -related disease	1549	1570
9949197	Emery-Dreifuss muscular dystrophy	68	101
9949197	Emery-Dreifuss muscular dystrophy	173	206
9949197	Emery-Dreifuss muscular dystrophy (EDMD)	173	213
9949197	EDMD	208	212
9949197	EDMD	1165	1169
9949197	EDMD	1456	1460
9949197	EDMD	1685	1689
9949209	copper toxicosis	23	39
9949209	copper toxicosis	637	653
9949209	hepatic copper accumulation	158	185
9949209	hepatic copper accumulation	272	299
9949209	inherited disorder	206	224
9949209	Wilson disease (WD)	346	365
9949209	copper overload disease	499	522
9949209	non-Indian childhood cirrhosis	523	553
9949209	copper toxicosis (CT)	637	658
9949209	progressive liver disease	726	751
9949209	WD	362	364
9949209	WD	777	779
9949209	WD	1147	1149
9950360	colorectal cancer	155	172
9950360	colorectal cancer	225	242
9950360	colorectal cancer	642	659
9950360	colorectal cancer	732	749
9950360	colorectal cancer	1069	1086
9950360	colorectal cancer	1658	1675
9950360	familial adenomatous polyposis (FAP)	298	334
9950360	adenomatous polyposis coli (APC) gene mutations	380	427
9950360	non-FAP colorectal cancer	634	659
9950360	non-FAP colorectal cancer	724	749
9950360	non-FAP colorectal cancer	1650	1675
9950360	FAP	96	99
9950360	FAP	330	333
9950360	FAP	638	641
9950360	FAP	713	716
9950360	FAP	728	731
9950360	FAP	943	946
9950360	FAP	1056	1059
9950360	FAP	1220	1223
9950360	FAP	1642	1645
9950360	FAP	1654	1657
9950360	extracolonic manifestations in FAP	1189	1223
9950360	life threatening conditions	1501	1528
9973276	colorectal polyposis	10	30
9973276	cancer	35	41
9973276	cancer	638	644
9973276	cancer	1050	1056
9973276	cancer	1267	1273
9973276	cancer	1518	1524
9973276	colorectal tumor formation	162	188
9973276	familial adenomatous polyposis syndrome	192	231
9973276	sporadic colorectal carcinogenesis	236	270
9973276	colorectal carcinogenesis	245	270
9973276	colorectal carcinogenesis	496	521
9973276	adenomatous polyps	600	618
9973276	colorectal cancer	627	644
9973276	colorectal cancer	1039	1056
9973276	colorectal cancer	1256	1273
9973276	colorectal cancer	1507	1524
9973276	colorectal neoplasia	904	924
9973276	adenomas	1026	1034
9973276	colorectal cancers	1039	1057
9988281	breast carcinomas	70	87
9988281	hereditary breast and ovarian cancer	152	188
9988281	non-familial cancers	235	255
9988281	sporadic cancers	296	312
9988281	non-familial breast and ovarian cancers	437	476
9988281	breast malignancies	996	1015
9988281	benign breast	1108	1121
9988281	invasive lobular cancers	1123	1147
9988281	low-grade ductal carcinomas	1152	1179
9988281	high-grade	44	54
9988281	high-grade	1257	1267
9988281	sporadic breast cancers	1387	1410
